The Federal Trade Commission (FTC) Friday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive practices. The FTC alleges that these practices have… Biden-Harris FTC Takes Legal Action Over Insulin Price Inflation